Announcements Trials
Browse Landscape

Phase

Phase EARLY_PHASE1 1Phase 2 1

Status

Terminated 1Completed 1

Sponsor Class

OTHER 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other hematologic neoplasm 2Lymphoid 2Classical hematology 2Plasma cell 1Myeloid 1

Conditions

Myelodysplastic Syndromes 43Leukemia 38Precursor Cell Lymphoblastic Leukemia-Lymphoma 37Leukemia, Myeloid, Acute 32Lymphoma 30Leukemia, Lymphocytic, Chronic, B-Cell 27Lymphoma, Mantle-Cell 26Lymphoma, Follicular 26Leukemia, Myeloid, Chronic-Phase 26Lymphoma, Non-Hodgkin 25Leukemia, Myeloid, Accelerated Phase 24Lymphoma, B-Cell, Marginal Zone 23Lymphoma, Large B-Cell, Diffuse 22Hodgkin Disease 22Burkitt Lymphoma 22Anemia, Refractory, with Excess of Blasts 22Multiple Myeloma 21Congenital Abnormalities 19Myeloproliferative Disorders 18Lymphoma, Large-Cell, Immunoblastic 18Blast Crisis 18Dendritic Cell Sarcoma, Interdigitating 17Anemia, Refractory 16Recurrence 15Neoplasms, Plasma Cell 15Leukemia, Myelogenous, Chronic, BCR-ABL Positive 14Leukemia, Myelomonocytic, Chronic 13Leukemia, Biphenotypic, Acute 13Primary Myelofibrosis 12Myelodysplastic-Myeloproliferative Diseases 12

Interventions

Cyclophosphamide 23fludarabine phosphate 19Whole-Body Irradiation 17fludarabine 16Melphalan 16Tacrolimus 14Busulfan 14Peripheral Blood Stem Cell Transplantation 11Mycophenolic Acid 11Alemtuzumab 9Cyclosporine 7Methotrexate 6Antilymphocyte Serum 6thymoglobulin 4Stem Cell Transplantation 4Thiotepa 3Methylprednisolone 3Granulocyte Colony-Stimulating Factor 3Etoposide 3AP 1903 reagent 3sargramostim 2Transplantation 2Sirolimus 2Rituximab 2Mesna 2Influenza Vaccines 2Immunoenzyme Techniques 2Hematopoietic Stem Cell Transplantation 2Flow Cytometry 2Filgrastim 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Anemia, Aplastic × Cord Blood Stem Cell Transplantation × Clear all
NCT00053989 2020-02-10

NMA Allogeneic Hematopoietic Cell Transplant in Hematologic Cancer/Disorders

Roswell Park Cancer Institute

Phase 2 Completed
41 enrolled 13 charts
Classical hematologyLymphoidMyeloidOther hematologic neoplasmPlasma cell

Congenital Abnormalities, Anemia, Aplastic, Anemia, Refractory, Anemia, Refractory, with Excess of Blasts, Burkitt Lymphoma, Fanconi Anemia, Hodgkin Disease, Leukemia, Lymphoma, Lymphoma, Follicular, Waldenstrom Macroglobulinemia, Multiple Myeloma, Myelodysplastic Syndromes, Myeloproliferative Disorders, Recurrence, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myeloid, Accelerated Phase, Leukemia, Myeloid, Chronic-Phase, Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Lymphoma, B-Cell, Marginal Zone, Precursor Cell Lymphoblastic Leukemia-Lymphoma, Neoplasms, Plasma Cell, Myelodysplastic-Myeloproliferative Diseases, Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative, Primary Myelofibrosis

NCT00212407 2018-11-02

New York Blood Center National Cord Blood Program

New York Blood Center

Phase EARLY_PHASE1 Terminated
4,476 enrolled
Classical hematologyLymphoidOther hematologic neoplasm

Anemia, Aplastic, Anemia, Refractory, with Excess of Blasts, Leukemia, Lymphoma, Genetic Diseases, Inborn

Data powered by HemOnc (CC BY 4.0) Colophon âš¡